Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project
The combination of serum β2-microglobulin and albumin levels has been shown to be highly prognostic in myeloma as the International Staging System (ISS). The aim of this study was to assess the independent contributions of ISS stage and cytogenetic abnormalities in predicting outcomes. A retrospecti...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2013
|
| In: |
Leukemia
Year: 2012, Jahrgang: 27, Heft: 3, Pages: 711-717 |
| ISSN: | 1476-5551 |
| DOI: | 10.1038/leu.2012.282 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/leu.2012.282 Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/leu2012282 
|
| Verfasserangaben: | H Avet-Loiseau, BGM Durie, M Cavo, M Attal, N Gutierrez, J Haessler, H Goldschmidt, R Hajek,JH Lee, O Sezer, B Barlogie,J Crowley, R Fonseca, N Testoni, F Ross, SV Rajkumar, P Sonneveld, J Lahuerta, P Moreau and G Morgan on behalf of the International Myeloma Working Group |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1736499262 | ||
| 003 | DE-627 | ||
| 005 | 20220819000730.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201023r20132012xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/leu.2012.282 |2 doi | |
| 035 | |a (DE-627)1736499262 | ||
| 035 | |a (DE-599)KXP1736499262 | ||
| 035 | |a (OCoLC)1341373301 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Avet-Loiseau, Hervé |e VerfasserIn |0 (DE-588)1220121037 |0 (DE-627)1736496964 |4 aut | |
| 245 | 1 | 0 | |a Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma |b an International Myeloma Working Group collaborative project |c H Avet-Loiseau, BGM Durie, M Cavo, M Attal, N Gutierrez, J Haessler, H Goldschmidt, R Hajek,JH Lee, O Sezer, B Barlogie,J Crowley, R Fonseca, N Testoni, F Ross, SV Rajkumar, P Sonneveld, J Lahuerta, P Moreau and G Morgan on behalf of the International Myeloma Working Group |
| 264 | 1 | |c 2013 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 23.10.2020 | ||
| 500 | |a First published: 23 October 2012 | ||
| 520 | |a The combination of serum β2-microglobulin and albumin levels has been shown to be highly prognostic in myeloma as the International Staging System (ISS). The aim of this study was to assess the independent contributions of ISS stage and cytogenetic abnormalities in predicting outcomes. A retrospective analysis of international studies looking at both ISS and cytogenetic abnormalities was performed in order to assess the potential role of combining ISS stage and cytogenetics to predict survival. This international effort used the International Myeloma Working Group database of 12 137 patients treated worldwide for myeloma at diagnosis, of whom 2309 had cytogenetic studies and 5387 had analyses by fluorescent in situ hybridization (iFISH). Comprehensive analyses used 2642 patients with sufficient iFISH data available. Using the comprehensive iFISH data, combining both t(4;14) and deletion (17p), along with ISS stage, significantly improved the prognostic assessment in terms of progression-free survival and overall survival. The additional impact of patient age and use of high-dose therapy was also demonstrated. In conclusion, the combination of iFISH data with ISS staging significantly improves risk assessment in myeloma. | ||
| 534 | |c 2012 | ||
| 700 | 1 | |a Durie, B. G. M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cavo, M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Attal, M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gutierrez, N. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Haessler, J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Goldschmidt, Hartmut |d 1956- |e VerfasserIn |0 (DE-588)102258023X |0 (DE-627)717003809 |0 (DE-576)365637386 |4 aut | |
| 700 | 1 | |a Hajek, R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lee, J. H. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sezer, O. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Barlogie, B. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Crowley, J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fonseca, R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Testoni, N. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ross, F. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rajkumar, S. V. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sonneveld, P. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lahuerta, J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Moreau, P. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Morgan, G. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia |d London : Springer Nature, 1997 |g 27(2013), 3, Seite 711-717 |h Online-Ressource |w (DE-627)32046699X |w (DE-600)2008023-2 |w (DE-576)094139733 |x 1476-5551 |7 nnas |a Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma an International Myeloma Working Group collaborative project |
| 773 | 1 | 8 | |g volume:27 |g year:2013 |g number:3 |g pages:711-717 |g extent:7 |a Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma an International Myeloma Working Group collaborative project |
| 856 | 4 | 0 | |u https://doi.org/10.1038/leu.2012.282 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/leu2012282 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20201023 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 102258023X |a Goldschmidt, Hartmut |m 102258023X:Goldschmidt, Hartmut |d 910000 |d 910100 |d 50000 |e 910000PG102258023X |e 910100PG102258023X |e 50000PG102258023X |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 7 | ||
| 999 | |a KXP-PPN1736499262 |e 3785449380 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"given":"Hervé","family":"Avet-Loiseau","display":"Avet-Loiseau, Hervé","role":"aut"},{"display":"Durie, B. G. M.","family":"Durie","given":"B. G. M.","role":"aut"},{"display":"Cavo, M.","family":"Cavo","given":"M.","role":"aut"},{"role":"aut","display":"Attal, M.","family":"Attal","given":"M."},{"given":"N.","family":"Gutierrez","display":"Gutierrez, N.","role":"aut"},{"role":"aut","given":"J.","family":"Haessler","display":"Haessler, J."},{"given":"Hartmut","family":"Goldschmidt","display":"Goldschmidt, Hartmut","role":"aut"},{"display":"Hajek, R.","family":"Hajek","given":"R.","role":"aut"},{"role":"aut","display":"Lee, J. H.","family":"Lee","given":"J. H."},{"role":"aut","family":"Sezer","given":"O.","display":"Sezer, O."},{"role":"aut","display":"Barlogie, B.","given":"B.","family":"Barlogie"},{"role":"aut","family":"Crowley","given":"J.","display":"Crowley, J."},{"given":"R.","family":"Fonseca","display":"Fonseca, R.","role":"aut"},{"role":"aut","display":"Testoni, N.","family":"Testoni","given":"N."},{"role":"aut","display":"Ross, F.","family":"Ross","given":"F."},{"role":"aut","family":"Rajkumar","given":"S. V.","display":"Rajkumar, S. V."},{"role":"aut","display":"Sonneveld, P.","given":"P.","family":"Sonneveld"},{"role":"aut","display":"Lahuerta, J.","given":"J.","family":"Lahuerta"},{"role":"aut","given":"P.","family":"Moreau","display":"Moreau, P."},{"display":"Morgan, G.","given":"G.","family":"Morgan","role":"aut"}],"title":[{"title":"Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma","title_sort":"Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma","subtitle":"an International Myeloma Working Group collaborative project"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"2013"}],"note":["Gesehen am 23.10.2020","First published: 23 October 2012"],"recId":"1736499262","id":{"doi":["10.1038/leu.2012.282"],"eki":["1736499262"]},"relHost":[{"language":["eng"],"disp":"Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma an International Myeloma Working Group collaborative projectLeukemia","physDesc":[{"extent":"Online-Ressource"}],"part":{"text":"27(2013), 3, Seite 711-717","issue":"3","year":"2013","extent":"7","pages":"711-717","volume":"27"},"id":{"eki":["32046699X"],"zdb":["2008023-2"],"issn":["1476-5551"]},"recId":"32046699X","note":["Gesehen am 15.03.04"],"origin":[{"publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke","dateIssuedDisp":"1997-","publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group","dateIssuedKey":"1997"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal","title_sort":"Leukemia","title":"Leukemia"}],"pubHistory":["Nachgewiesen 11.1997 -"]}],"name":{"displayForm":["H Avet-Loiseau, BGM Durie, M Cavo, M Attal, N Gutierrez, J Haessler, H Goldschmidt, R Hajek,JH Lee, O Sezer, B Barlogie,J Crowley, R Fonseca, N Testoni, F Ross, SV Rajkumar, P Sonneveld, J Lahuerta, P Moreau and G Morgan on behalf of the International Myeloma Working Group"]},"physDesc":[{"extent":"7 S."}],"language":["eng"]} | ||
| SRT | |a AVETLOISEACOMBININGF2013 | ||